
Keywords: ACS; acute coronary syndrome; BP-BES; biolimus-eluting stent with biodegradable polymer; DES; drug-eluting stent; EES; everolimus-eluting stent; O-SES; Orsiro sirolimus-eluting stent; PCI; percutaneous coronary intervention; RCT; randomized controlled tri